Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 74 of 102, showing 5 Applications out of 508 total, starting on record 366, ending on 370

# Protocol No Study Title Investigator(s) & Site(s)

366.

ECCT/22/08/03   NeoSep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of clinically diagnosed neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christina Wesonga Obiero
2. James Alexander Berkley
Site(s) in Kenya
1. Kilifi County Hospital, KEMRI- Wellcome Trust Research Programme (KWTRP) (Kilifi county)
 
View

367.

ECCT/23/06/08   TSCV3000
    Age-descending, randomized, placebo-controlled Phase 2 trial in three sites in sub-Saharan Africa to assess the safety and immunogenicity of a parenteral Trivalent Salmonella (S. Enteritidis/S. Typhimurium/S. Typhi Vi) Conjugate Vaccine (TSCV) versus placebo   
Principal Investigator(s)
1. RICHARD ONYANDO OMORE
Site(s) in Kenya
1. SIAYA COUNTY REFERRAL HOSPITAL (Siaya county)
2. ST. ELIZABETH LWAK HOSPITAL (Siaya county)
 
View

368.

ECCT/21/11/02   SONIA Trial
    A Pragmatic Randomized Controlled Trial of Standard Care versus Steroids plus Standard Care for Treatment of Pneumonia in Adults Admitted to Kenyan Hospitals       
Principal Investigator(s)
1. Anthony Oliwa Etyang
2. Samuel Owuor Akech
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Mbagathi Sub-county Hospital (Nairobi City county)
3. Busia County Referral Hospital (Busia county)
4. Bungoma County Referral Hospital (Bung\'oma county)
5. Kisumu County Hospital (Kisumu county)
6. Machakos Level 5 Hospital (Machakos county)
7. Mama Lucy Kibaki Hospital (Nairobi City county)
8. Kitale County Referral Hospital (Trans Nzoia county)
9. Kiambu County Hospital (Kiambu county)
10. Kakamega County Hospital (Kakamega county)
 
View

369.

ECCT/14/09/01   Extension to study MALARIA-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa
    An open extension to the phase III, multi-center study MALARIA-055 PRI (110021) to evaluate long-term efficacy, safety and immunogenicity of the RTS,S/AS01E candidate vaccine against malaria disease caused by Plasmodium falciparum in infants and children in Africa.   Study number: MALARIA-076 (200599)   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project
 
View

370.

ECCT/23/04/04   AGREE
    Oral antenatal L-citrulline supplementation to reduce adverse pregnancy outcomes: a two-arm, randomized, placebo-controlled multi-site trial in Kenya   
Principal Investigator(s)
1. Hellen Barsosio
Site(s) in Kenya
1. Ahero County Hospital (Kisumu county)
2. Alupe sub-county Hospital (Busia county)
3. Siaya County Referral Hospital (Siaya county)
 
View